Regulation of spinal neuroimmune responses by prolonged morphine treatment in a rat model of cancer induced bone pain
暂无分享,去创建一个
F. Gao | X. Tian | Honghui Yu | Fei Cao | Hui Yang | Yu-ke Tian | Xue-ren Wang | W. Mei | Sha-sha Chen | Xing-peng Xiao | Xi-jiang Liu | Shao-bing Yang | Ai-jun Xu | Zhi-jun Chen | Yu‐ke Tian
[1] V. Ruíz-García,et al. Morphine remains gold standard in breakthrough cancer pain , 2008, BMJ : British Medical Journal.
[2] E. Hansson,et al. μ-Opioid agonists inhibit the enhanced intracellular Ca2+ responses in inflammatory activated astrocytes co-cultured with brain endothelial cells , 2008, Neuroscience.
[3] M. Fallon,et al. Translational medicine: cancer pain mechanisms and management. , 2008, British journal of anaesthesia.
[4] A. Beitz,et al. Animal models of cancer pain. , 2008, Comparative medicine.
[5] M. Fallon,et al. Challenges in cancer pain management--bone pain. , 2008, European journal of cancer.
[6] M. Shakibaei,et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. , 2008, The Journal of clinical investigation.
[7] S. Skaper. The Brain as a Target for Inflammatory Processes and Neuroprotective Strategies , 2007, Annals of the New York Academy of Sciences.
[8] S. Maier,et al. “Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids , 2007, Brain Research Reviews.
[9] S. Maier,et al. A novel immune-to-CNS communication pathway: Cells of the meninges surrounding the spinal cord CSF space produce proinflammatory cytokines in response to an inflammatory stimulus , 2007, Brain, Behavior, and Immunity.
[10] K. E. Clemens,et al. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study. , 2007, Japanese journal of clinical oncology.
[11] S. Maier,et al. Glia as the “bad guys”: Implications for improving clinical pain control and the clinical utility of opioids , 2007, Brain, Behavior, and Immunity.
[12] D. Clohisy,et al. Biology of Bone Cancer Pain , 2006, Clinical Cancer Research.
[13] P. Mantyh. Cancer pain and its impact on diagnosis, survival and quality of life , 2006, Nature Reviews Neuroscience.
[14] Jhi-Joung Wang,et al. Amitriptyline suppresses neuroinflammation and up-regulates glutamate transporters in morphine-tolerant rats , 2006, Pain.
[15] Jun Zhao,et al. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. , 2006, Biochemical and biophysical research communications.
[16] A. Terry,et al. ELISA methods to measure cholinergic markers and nerve growth factor receptors in cortex, hippocampus, prefrontal cortex, and basal forebrain from rat brain , 2006, Journal of Neuroscience Methods.
[17] Jian-qiang Feng,et al. Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance , 2006, Brain Research.
[18] A. Dickenson,et al. Efficacy of chronic morphine in a rat model of cancer-induced bone pain: behavior and in dorsal horn pathophysiology. , 2005, The journal of pain : official journal of the American Pain Society.
[19] I. Kissin. Tolerance to opioid analgesia: why do we differ from rats? , 2005, Anesthesia and analgesia.
[20] L. Lao,et al. Spinal glial activation in a new rat model of bone cancer pain produced by prostate cancer cell inoculation of the tibia , 2005, Pain.
[21] C. Quigley,et al. The role of opioids in cancer pain , 2005, BMJ : British Medical Journal.
[22] Mellar P. Davis,et al. Controversies in pharmacotherapy of pain management. , 2005, The Lancet. Oncology.
[23] V. Tawfik,et al. Transcriptional and Translational Regulation of Glial Activation by Morphine in a Rodent Model of Neuropathic Pain , 2005, Journal of Pharmacology and Experimental Therapeutics.
[24] P. Mantyh,et al. Bone cancer pain: from model to mechanism to therapy. , 2005, Journal of pain and symptom management.
[25] A. Dickenson,et al. Gabapentin Normalizes Spinal Neuronal Responses That Correlate with Behavior in a Rat Model of Cancer-induced Bone Pain , 2005, Anesthesiology.
[26] S. Maier,et al. Behavioral/systems/cognitive a Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerance, and Subsequent Pain Facilitation Induced by Chronic Intrathecal Morphine , 2022 .
[27] J. Deleo,et al. Complete Freunds adjuvant‐induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS , 2004, The European journal of neuroscience.
[28] J. Deleo,et al. Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain , 2004, Neurochemistry International.
[29] C. Urch. The pathophysiology of cancer-induced bone pain: current understanding , 2004, Palliative medicine.
[30] J. Deleo,et al. Attenuation of Morphine Tolerance, Withdrawal-Induced Hyperalgesia, and Associated Spinal Inflammatory Immune Responses by Propentofylline in Rats , 2004, Neuropsychopharmacology.
[31] V. Tawfik,et al. Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia , 2004, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[32] A. Dickenson,et al. Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain , 2003, Pain.
[33] S. Maier,et al. GLIA: A novel drug discovery target for clinical pain , 2003, Nature Reviews Drug Discovery.
[34] J. Deleo,et al. Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines , 2003, Pain.
[35] J. Deleo,et al. The Role of Spinal Neuroimmune Activation in Morphine Tolerance/Hyperalgesia in Neuropathic and Sham-Operated Rats , 2002, The Journal of Neuroscience.
[36] T. O'reilly,et al. A rat model of bone cancer pain , 2002, Pain.
[37] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[38] P. Song,et al. The involvement of glial cells in the development of morphine tolerance , 2001, Neuroscience Research.
[39] Marc G. Caron,et al. μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence , 2000, Nature.
[40] V. Kayser,et al. The development of pain-related behaviour and opioid tolerance after neuropathy-inducing surgery and sham surgery , 2000, PAIN.
[41] P. Mantyh,et al. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons , 2000, Neuroscience.
[42] S. Mercadante. Problems of long-term spinal opioid treatment in advanced cancer patients , 1999, Pain.
[43] S. Mercadante,et al. Breakthrough pain in cancer patients: pathophysiology and treatment. , 1998, Cancer treatment reviews.
[44] W. Hickey,et al. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat , 1997, Journal of Neuroimmunology.
[45] John Lynch,et al. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study , 1995, Pain.
[46] T. Yaksh,et al. Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.
[47] M. Zimmermann,et al. Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.
[48] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[49] L. Watkins,et al. Pathological and protective roles of glia in chronic pain , 2009, Nature Reviews Neuroscience.
[50] J T Williams,et al. Cellular and synaptic adaptations mediating opioid dependence. , 2001, Physiological reviews.
[51] R. Gainetdinov,et al. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. , 2000, Nature.
[52] R. Portenoy,et al. Pain management: pharmacological approaches. , 1999, Cancer treatment and research.
[53] B. Chir.,et al. Cancer pain. , 1987, The Medical clinics of North America.
[54] J. Bonica,et al. Management of cancer pain. , 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[55] Rae Baxter,et al. Acknowledgments.-The authors would like to , 1982 .
[56] W. Dixon,et al. Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.